Since heterogeneity in concentrations of TNF-α and IL-6 was found at different stages of normal pregnancy, it is necessary to further characterize their concentrations at certain time points during pregnancy, which would make TNF-α and IL-6 relevant markers for GDM. This evidence concerns the gene TNF and gestational diabetes.